Santen Pharmaceutical
4536.T
#3522
Rank
NZ$7.31 B
Marketcap
NZ$22.77
Share price
6.68%
Change (1 day)
29.55%
Change (1 year)

Operating Margin for Santen Pharmaceutical (4536.T)

Operating Margin as of November 2026 (TTM): 17.23%

According to Santen Pharmaceutical 's latest financial reports and stock price the company's current Operating Margin is 17.23%. At the end of 2022 the company had an Operating Margin of 13.83%.

Operating Margin history for Santen Pharmaceutical from 2009 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202213.83%148.25%
20215.57%-60.97%
202014.28%-27.37%
201919.66%11.38%
201817.65%5.23%
201716.77%-59.55%
201641.46%85.63%
201522.33%23.43%
201418.09%-15.84%
201321.50%-11.56%
201224.31%-13.41%
201128.07%8.33%
201025.92%65.76%
200915.64%-21.44%
200819.90%-5.35%
200721.03%1.25%
200620.77%3.39%
200520.09%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.